Hyaluronic acid composite NPs, modified with 1-methyl-DL-tryptophan, a molecule that inhibits indoleamine-2, 3-dioxygenase, and loaded with an anti-PD-1 antagonist, were effective in a melanoma mouse model (Ye et al., 2016). Here, PDCD1 is linked to melanoma.